Your browser doesn't support javascript.
loading
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.
Bousquet, Jean; Schünemann, Holger J; Hellings, Peter W; Arnavielhe, Sylvie; Bachert, Claus; Bedbrook, Anna; Bergmann, Karl-Christian; Bosnic-Anticevich, Sinthia; Brozek, Jan; Calderon, Moises; Canonica, G Walter; Casale, Thomas B; Chavannes, Niels H; Cox, Linda; Chrystyn, Henry; Cruz, Alvaro A; Dahl, Ronald; De Carlo, Giuseppe; Demoly, Pascal; Devillier, Phillipe; Dray, Gérard; Fletcher, Monica; Fokkens, Wytske J; Fonseca, Joao; Gonzalez-Diaz, Sandra N; Grouse, Lawrence; Keil, Thomas; Kuna, Piotr; Larenas-Linnemann, Désirée; Lodrup Carlsen, Karin C; Meltzer, Eli O; Mullol, Jaoquim; Muraro, Antonella; Naclerio, Robert N; Palkonen, Susanna; Papadopoulos, Nikolaos G; Passalacqua, Giovanni; Price, David; Ryan, Dermot; Samolinski, Boleslaw; Scadding, Glenis K; Sheikh, Aziz; Spertini, François; Valiulis, Arunas; Valovirta, Erkka; Walker, Samantha; Wickman, Magnus; Yorgancioglu, Arzu; Haahtela, Tari; Zuberbier, Torsten.
Afiliação
  • Bousquet J; University Hospital, Montpellier, France; MACVIA-LR, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon, European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France; INSERM, VIMA: Ageing and Chronic Diseases, Epidemiological and P
  • Schünemann HJ; Departments of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Hellings PW; Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Arnavielhe S; Kyomed, Montpellier, France.
  • Bachert C; Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
  • Bedbrook A; MACVIA-LR, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon, European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
  • Bergmann KC; Allergy-Centre-Charité at the Department of Dermatology, Charité-Universitätsmedizin Berlin, and Secretary General of the Global Allergy and Asthma European Network (GA(2)LEN), Berlin, Germany.
  • Bosnic-Anticevich S; Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, Australia.
  • Brozek J; Departments of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Calderon M; Imperial College London-National Heart and Lung Institute, Royal Brompton Hospital NHS, London, United Kingdom.
  • Canonica GW; Allergy and Respiratory Diseases Clinic, DIMI, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Casale TB; Division of Allergy/Immunology, University of South Florida, Tampa, Fla.
  • Chavannes NH; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
  • Cox L; Department of Medicine, Nova Southeastern University, Davie, Fla.
  • Chrystyn H; RiRL, Cambridge, United Kingdom.
  • Cruz AA; ProAR-Nucleo de Excelencia em Asma, Federal University of Bahia, and GARD Executive Committee, Bahia, Brazil.
  • Dahl R; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
  • De Carlo G; EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
  • Demoly P; EPAR U707 INSERM, Paris and EPAR UMR-S UPMC, Paris VI, Paris, France; Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
  • Devillier P; Laboratoire de Pharmacologie Respiratoire UPRES EA220, Hôpital Foch, Suresnes Université Versailles Saint-Quentin, St-Quentin-en-Yvelines, France.
  • Dray G; Ecole des Mines, Alès, France.
  • Fletcher M; Education for Health, Warwick, United Kingdom.
  • Fokkens WJ; Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
  • Fonseca J; Center for Research in Health Technologies and Information Systems-CINTESIS, Universidade do Porto; the Allergy Unit, Instituto CUF Porto e Hospital CUF Porto; the Health Information and Decision Sciences Department-CIDES, Faculdade de Medicina, Universidade do Porto; Faculdade de Medicina da Univer
  • Gonzalez-Diaz SN; Universidad Autónoma de Nuevo León, Nuevo León, Mexico.
  • Grouse L; University of Washington School of Medicine, Faculty of the Department of Neurology, Seattle, Wash.
  • Keil T; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, and the Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
  • Kuna P; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
  • Larenas-Linnemann D; Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, Mexico City, Mexico.
  • Lodrup Carlsen KC; Department of Paediatrics, Oslo University Hospital, Oslo, and the Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Meltzer EO; Allergy and Asthma Medical Group and Research Center, San Diego, Calif.
  • Mullol J; Unitat de Rinologia i Clínica de l'Olfacte, Servei d'ORL, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, Barcelona, Spain.
  • Muraro A; Food Allergy Referral Centre Veneto Region, Department of Women and Child Health, Padua General University Hospital, Padua, Italy.
  • Naclerio RN; Section of Otolaryngology-Head and Neck Surgery, University of Chicago Medical Center and Pritzker School of Medicine, University of Chicago, Chicago, Ill.
  • Palkonen S; EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
  • Papadopoulos NG; Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, and the Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
  • Passalacqua G; Allergy and Respiratory Diseases Clinic, DIMI, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Price D; Academic Centre of Primary Care, University of Aberdeen, and Research in Real-Life, Cambridge, United Kingdom.
  • Ryan D; Honorary Clinical Research Fellow, Allergy and Respiratory Research Group, University of Edinburgh, Edinburgh, United Kingdom.
  • Samolinski B; Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
  • Scadding GK; Royal National TNE Hospital, University College London, London, United Kingdom.
  • Sheikh A; Allergy and Respiratory Research Group, Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United Kingdom.
  • Spertini F; Service d'Immunologie et Allergie, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Valiulis A; Vilnius University Clinic of Children's Diseases, Vilnius, Lithuania.
  • Valovirta E; Department of Lung Diseases and Clinical Allergology, University of Turku, Turku, Finland.
  • Walker S; Asthma UK, London, United Kingdom.
  • Wickman M; Sachs' Children's Hospital, Stockholm, and the Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Yorgancioglu A; Department of Pulmonology, Celal Bayar University Manisa, Turkey, and GARD Executive Committee, Manisa, Turkey.
  • Haahtela T; Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
  • Zuberbier T; Allergy-Centre-Charité at the Department of Dermatology, Charité-Universitätsmedizin Berlin, and Secretary General of the Global Allergy and Asthma European Network (GA(2)LEN), Berlin, Germany.
J Allergy Clin Immunol ; 138(2): 367-374.e2, 2016 08.
Article em En | MEDLINE | ID: mdl-27260321
ABSTRACT
The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment adjustment is required. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control. CDSSs should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine treatment and its step-up or step-down strategy depending on AR control. Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR [fighting chronic diseases for active and healthy ageing]), one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (the MACVIA-ARIA Sentinel Network). A CDSS is currently being developed to optimize AR control. An algorithm developed by consensus is presented in this article. This algorithm should be confirmed by appropriate trials.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Rinite Alérgica Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Rinite Alérgica Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2016 Tipo de documento: Article